Abstract | BACKGROUND: The FX class of haemodialysers features a new class of high-flux polysulfone membrane which has been suggested to induce less inflammation. METHODS: This was a randomized, cross-over study performed on 33 haemodialysis patients. Patients were randomized to FX60 or HF80 dialysers for 3 months and then changed to the other dialyser. Interleukin-6 (IL-6), tumour necrosis factor-alpha ( TNF-alpha), and C-reactive protein (CRP) were measured at baseline, and every 3 months. The Kidney Disease Quality of Life Short Form was also administered. RESULTS: The mean of the difference in the IL-6 level between dialysers was 1.4 +/- 8.0 pg/ml (95% CI -1.8, 4.5 pg/ml). There was no significant difference in TNF-alpha (95% CI -0.35, 0.18 pg/ml) or CRP levels (95% CI -2.67, 6.20 mg/l). The quality of social interaction and role limitations caused by physical health problems were significantly higher with the FX60, p = 0.04 and 0.047, respectively. CONCLUSIONS: The FX dialysers do not result in a significant difference in the level of systemic inflammation compared to the HF80.
|
Authors | Neil Boudville, Marilyn Horner, Elizabeth McEwan, Wai H Lim, David W Mudge, Hadley E Markus |
Journal | Blood purification
(Blood Purif)
Vol. 27
Issue 2
Pg. 187-93
( 2009)
ISSN: 1421-9735 [Electronic] Switzerland |
PMID | 19141998
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-6
- Recombinant Proteins
- Tumor Necrosis Factor-alpha
- Erythropoietin
- Darbepoetin alfa
- Epoetin Alfa
- C-Reactive Protein
|
Topics |
- Adult
- Aged
- C-Reactive Protein
(metabolism)
- Cross-Over Studies
- Darbepoetin alfa
- Epoetin Alfa
- Erythropoietin
(administration & dosage, analogs & derivatives)
- Female
- Humans
- Inflammation
(drug therapy)
- Interleukin-6
(metabolism)
- Male
- Middle Aged
- Quality of Life
(psychology)
- Recombinant Proteins
- Renal Dialysis
(instrumentation, psychology)
- Tumor Necrosis Factor-alpha
(metabolism)
|